HLB Therapeutics Co.,Ltd.

₩2,405As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:115450Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (9.98%)
Div yield —
ROE (10.85%)
Biotechnology
Beta (5Y) (0.54)
PE TTM —
TSR TTM (24.28%)
Mkt cap ₩212.0B
ROIC (4.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,895
20.36%
(5.05%)
Hold 7|9|3|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
31.69
30.61
30.00
31.95
8.85%
6.79%
3.30%
2.68%
Revenue₩B
15.29
15.60
16.42
16.01
(4.00%)
(1.10%)
3.30%
2.24%
Peers (US$156.3M)
Cap (US$)
PE
200.2M
—
159.2M
—
156.3M
8.576x
Capital
TTM
5Y
10Y
Leveragex
0.696
0.102
0.085
EBIT/Intx
8.894
0.475
0.352
Own earn%
(63.68)
24.75
27.20
Sh yield%
14.53
65.58
61.87
Owners
Insiders/Inst%
8.46
41.21
Short interest%
3.64
SBC / revenue%
2.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
14–18
$1 testx
—
Incr. ROIC%
56